SANW - Calyxt Using A More Conventional Model To Pursue Significant New Agri-Bio Market Opportunities
- Calyxt has changed its operating strategy to a more conventional agri-bio seed/trait model similar to those pursued by established agri-bio names like Bayer and Corteva.
- Calyxt is targeting new high-risk/high-reward market opportunities including winter oats, hemp, and soybeans with saturated fat content that could be a substitute for palm oil.
- I see an $11 fair value today on the assumption of $500M in 2030 revenue, but market acceptance is a meaningful risk and Calyxt will likely need to raise cash.
For further details see:
Calyxt Using A More Conventional Model To Pursue Significant New Agri-Bio Market Opportunities